RetinalGenix Technologies Inc
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remot… Read more
Market Cap & Net Worth: RetinalGenix Technologies Inc (RTGN)
RetinalGenix Technologies Inc (OTCQB:RTGN) has a market capitalization of $93.40 Million ($93.40 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #23568 globally and #8223 in its home market, demonstrating a 149.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RetinalGenix Technologies Inc's stock price $5.02 by its total outstanding shares 18604961 (18.60 Million).
RetinalGenix Technologies Inc Market Cap History: 2022 to 2025
RetinalGenix Technologies Inc's market capitalization history from 2022 to 2025. Data shows growth from $167.44 Million to $93.40 Million (18.02% CAGR).
RetinalGenix Technologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RetinalGenix Technologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of RTGN by Market Capitalization
Companies near RetinalGenix Technologies Inc in the global market cap rankings as of March 19, 2026.
Key companies related to RetinalGenix Technologies Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
RetinalGenix Technologies Inc Historical Marketcap From 2022 to 2025
Between 2022 and today, RetinalGenix Technologies Inc's market cap moved from $167.44 Million to $ 93.40 Million, with a yearly change of 18.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $93.40 Million | +213.75% |
| 2024 | $29.77 Million | -48.22% |
| 2023 | $57.49 Million | -65.67% |
| 2022 | $167.44 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of RetinalGenix Technologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $93.40 Million USD |
| MoneyControl | $93.40 Million USD |
| MarketWatch | $93.40 Million USD |
| marketcap.company | $93.40 Million USD |
| Reuters | $93.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.